- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Report
- February 2022
- 210 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Report
- September 2024
- 82 Pages
Japan
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- September 2024
- 82 Pages
Japan
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- August 2024
- 80 Pages
Japan
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- May 2024
- 185 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- April 2024
- 190 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- October 2023
- 190 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- June 2023
- 112 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- December 2022
- 116 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- May 2024
- 174 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- April 2023
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- August 2022
- 111 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- August 2022
- 110 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- June 2022
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2023
- 48 Pages
Global
From €3587EUR$3,995USD£3,055GBP
- Report
- October 2021
- 288 Pages
Global
From €3232EUR$3,600USD£2,753GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more